Synopsis

Source of validity: Scientific
Rating (out of 5): 3

English Ivy (Hedera helix) leaf extract has been traditionally used in Europe as a remedy for coughs, particularly those associated with bronchitis and spastic cough. In recent years, its use has been supported by some scientific evidence. The active constituents, mainly saponins such as alpha-hederin, are believed to exert expectorant, bronchodilatory, and secretolytic effects, which may help reduce cough frequency and severity.

Several clinical studies, mostly conducted in Germany and other European countries, have evaluated standardized English Ivy extracts (often in the form of syrups). Some randomized controlled trials and observational studies suggest that ivy leaf preparations can improve symptoms of acute bronchitis and productive cough in both adults and children, with a favorable safety profile. However, many of these studies have methodological limitations, such as small sample sizes, lack of placebo controls, and variable extract standardization.

Based on a 2010 systematic review (Cochrane Database, 2010), the overall quality of evidence is moderate, and more rigorous studies are needed to confirm efficacy, especially for spastic (non-productive) cough. Nevertheless, regulatory agencies in Europe (e.g., German Commission E, EMA) recognize ivy leaf extract as a traditional herbal medicinal product for cough and bronchitis. Thus, while there is scientific validation, the strength of evidence is moderate rather than high.

More about English Ivy
More about Cough (spastic)

Other ingredients used for Cough (spastic)

Other health conditions supported by English Ivy

Products containing English Ivy